NSE: DEEPAKNTR | BSE: 506401

Slowing Down Stock

Download real time

1936.60 -12.30 (-0.63%)

38.89% Fall from 52W High

82,435 NSE+BSE Volume

NSE 21 Jul, 2025 3:31 PM (IST)

26,413.9

Market Cap

Market Leader

1.2

Beta 1Year

Very High Volatility

Deepak Nitrite Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for DEEPAKNTR, BSE:506401 Deepak Nitrite Ltd.

Deepak Nitrite Ltd.

26 Jan 2022

1936.60

-0.63%

Margin continues to decline; demand remains strong

Neutral: Deepak Nitrite Ltd.

Target

Motilal Oswal

DN reported a miss on our estimates. EBITDA came in 8% lower than our estimate at INR3.5b, while EBITDA margin, at 20.4%, was lower than our estimate of 25.1%, the lowest since 4QFY19. Phenolics continued its strong growth, with Basic Intermediates and the Performance Products segment performing well in 3QFY22. EBIT margin in the Fine and Specialty Chemicals fell for the fifth...

Deepak Nitrite Ltd. is trading below all available SMAs

Deepak Nitrite Ltd.

28 Oct 2021

1936.60

-0.63%

Margin normalization at the cost of near term earnings growth

Neutral: Deepak Nitrite Ltd.

Motilal Oswal

DN reported a mixed bag result, with EBITDA 10% higher than our estimate at INR3.9b, while EBITDA margin was lower at 23% (est. 26.7%) the lowest since 4QFY19. Phenolics continue to act as a drag on performance of other segments, as the EBIT margin in Fine and Specialty Chemicals dip for the fourth consecutive quarter and the same for Basic Chemicals normalize. EBIT mix continues to remain largely the same for the last three quarters, with contribution from Phenolics at 63% (up from an average of 51% in FY21). This comes at the cost of a decline in contribution from the most margin lucrative Fine...

Deepak Nitrite Ltd. has an average target of 2131.67 from 3 brokers.

Deepak Nitrite Ltd.

24 May 2021

1936.60

-0.63%

Deepak Nitrite Ltd.

Accumulate: Deepak Nitrite Ltd.

Target

CD Equisearch

Bolstered by phenolics and fine & speciality chemicals business, DNL's income from operations rose apace in Q4 with the phenolics accounting for nearly two-thirds of the whole. Swiftly pacing, its phenol business logged capacity utilization in excess of 115% when compared to 98% in the same quarter a year ago. With little scoping of draining out reward of operating leverage at such record production churn, its EBIT margins admirably...

Number of FII/FPI investors increased from 229 to 235 in Jun 2025 qtr.

Deepak Nitrite Ltd.

09 May 2021

1936.60

-0.63%

Deepak Nitrite Ltd | Q4FY21 Result Update

Buy: Deepak Nitrite Ltd.

Recommendation Target

Edelweiss

A stellar quarter

Deepak Nitrite Ltd. has lost -30.66% in the last 1 Year

Deepak Nitrite Ltd.

26 Apr 2021

1936.60

-0.63%

Pick of the Week - Deepak Nitrite Limited

Neutral: Deepak Nitrite Ltd.

Recommendation Target

Edelweiss

Deepak Nitrite Limited manufactures chemical intermediates.

Deepak Nitrite Ltd. is trading below all available SMAs

Deepak Nitrite Ltd.

17 Feb 2021

1936.60

-0.63%

Deepak Nitrite Ltd - Result Update Q3FY21

Buy: Deepak Nitrite Ltd.

Target

Edelweiss

Strong quarter; commentary on capex encouraging

Deepak Nitrite Ltd. is trading below all available SMAs

Deepak Nitrite Ltd.

16 Aug 2020

1936.60

-0.63%

Deepak Nitrite Ltd - Result Update Q1FY21

Buy: Deepak Nitrite Ltd.

Target

Edelweiss

Though Deepak Nitrite's (DEN) Q1FY21 performance was impacted by the novel coronavirus.

Deepak Nitrite Ltd. is trading below all available SMAs

Deepak Nitrite Ltd.

31 May 2020

1936.60

-0.63%

Deepak Nitrite Ltd | Q4FY20 Result Update

Buy: Deepak Nitrite Ltd.

Target

Edelweiss

Deepak Nitrite (DEN) posted another strong performance in Q4FY20. Impact from COVID-19 led nationwide lockdown was counterbalanced by consistent margin profiles across business segments.

Deepak Nitrite Ltd.'s price crossed below 30Day SMA today

Deepak Nitrite Ltd.

23 Apr 2020

1936.60

-0.63%

Deepak Nitrite Ltd.

Accumulate: Deepak Nitrite Ltd.

Target

CD Equisearch

Dazzled by all but miraculous showing of DNL's barely pretentious performance products business in last few quarters, DNL's consolidated PBT surged by all but astonishing 377.6% in the first nine months of FY20 compared to that in the same period a year ago. Thanks to pinched supply of DASDA globally, DNL's performance products business EBIT leapfrogged nearly tenfold in the reported period, though sales advanced by a miserly 2x. Yet margins of performance products have moderated in last few quarters, declining to 54.1% in Q3 from 58.1% in Q1, with further...